Cellectar Biosciences, Inc. Gain (Loss) on Disposition of Assets
Cellectar Biosciences, Inc. (CLRB) reported Gain (Loss) on Disposition of Assets of -$145.73 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-03-04
- Cellectar Biosciences, Inc. gain (loss) on disposition of assets for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Cellectar Biosciences, Inc. gain (loss) on disposition of assets for the quarter ending 2022-09-30 was $0.00.
- Cellectar Biosciences, Inc. gain (loss) on disposition of assets for the quarter ending 2021-12-31 was $1.00.
- Cellectar Biosciences, Inc. gain (loss) on disposition of assets for the quarter ending 2021-09-30 was $0.00.
- Cellectar Biosciences, Inc. gain (loss) on disposition of assets for fiscal 2024 was -$145.73K.
- Cellectar Biosciences, Inc. gain (loss) on disposition of assets for fiscal 2022 was -$3.39K.
- Cellectar Biosciences, Inc. gain (loss) on disposition of assets for fiscal 2021 was -$2.94K.
- Cellectar Biosciences, Inc. gain (loss) on disposition of assets for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$145.73K 10-K · filed 2026-03-04 | |||
| 2022-12-31 | $0.00 derived: 10-K/A 12 month − 10-K/A 9 month · filed 2024-10-29 | $0.00 derived: sum of 2 quarters · filed 2024-10-29 | -$3.39K 10-K/A · filed 2024-10-29 | |
| 2022-09-30 | $0.00 derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-10-29 | -$3.39K 10-K/A · filed 2024-10-29 | ||
| 2022-06-30 | -$3.39K 10-K/A · filed 2024-10-29 | |||
| 2021-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $1.00 derived: sum of 2 quarters · filed 2023-03-09 | $1.00 derived: sum of 3 quarters · filed 2023-03-09 | -$2.94K 10-K · filed 2023-03-09 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | -$2.94K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$2.94K 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | -$2.94K 10-Q · filed 2022-05-10 | |||
| 2019-12-31 | $0.00 10-K · filed 2020-03-09 | |||
| 2018-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $50.90K 10-K · filed 2020-03-09 | ||
| 2018-09-30 | $40.90K 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 10-K · filed 2019-02-26 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |